KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Equity (2016 - 2025)

Historic Return on Equity for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • Pfizer's Return on Equity changed 0.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Pfizer's Return on Equity is 0.0%, which was down 0.0% from 0.0% recorded in Q2 2025.
  • Pfizer's Return on Equity's 5-year high stood at 0.02% during Q2 2021, with a 5-year trough of 0.0% in Q4 2021.
  • In the last 5 years, Pfizer's Return on Equity had a median value of 0.0% in 2022 and averaged 0.0%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -1600bps in 2021, then changed by 0bps in 2022.
  • Quarter analysis of 5 years shows Pfizer's Return on Equity stood at 0.0% in 2021, then surged by 102bps to 0.0% in 2022, then crashed by -330bps to 0.0% in 2023, then soared by 127bps to 0.0% in 2024, then surged by 521bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q3 2025, 0.0% for Q2 2025, and 0.0% during Q1 2025.